PortfoliosLab logoPortfoliosLab logo
HIVE Blockchain Technologies Ltd (HIVE)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
CA43366H1001
IPO Date
Jan 12, 2018

Highlights

Market Cap
$454.17M
Enterprise Value
$462.13M
EPS (TTM)
-$0.33
Total Revenue (TTM)
$257.14M
Gross Profit (TTM)
$58.57M
EBITDA (TTM)
$87.81M
Year Range
$1.26 - $7.84
Target Price
$7.00
ROA (TTM)
-11.53%
ROE (TTM)
-12.87%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in HIVE Blockchain Technologies Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

HIVE Blockchain Technologies Ltd (HIVE) has returned -26.36% so far this year and 31.03% over the past 12 months.


HIVE Blockchain Technologies Ltd

1D
8.57%
1M
-11.21%
YTD
-26.36%
6M
-52.85%
1Y
31.03%
3Y*
-16.72%
5Y*
-37.45%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 12, 2018, HIVE's average daily return is +0.14%, while the average monthly return is +3.35%. At this rate, your investment would double in approximately 1.8 years.

Historically, 43% of months were positive and 57% were negative. The best month was Nov 2020 with a return of +152.9%, while the worst month was Jun 2018 at -40.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HIVE closed higher 42% of trading days. The best single day was Nov 30, 2020 with a return of +44.9%, while the worst single day was Mar 9, 2020 at -25.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20268.14%-23.30%-11.21%-26.36%
20252.81%-29.35%-29.95%16.55%6.51%-0.00%18.89%37.85%36.61%29.03%-35.38%-23.21%-9.47%
2024-30.02%20.19%-11.55%-24.63%-0.79%22.22%17.86%-14.05%0.32%17.89%10.57%-30.15%-37.09%
2023140.28%-17.63%15.44%-1.52%0.00%42.90%17.06%-32.66%-15.62%-0.65%0.33%47.56%214.58%
2022-24.62%2.51%4.41%-31.46%-39.86%-31.89%50.84%12.86%-26.13%-17.82%-31.72%-31.75%-89.09%
20210.53%112.11%-3.23%-3.85%-33.06%13.92%-10.12%23.74%-16.04%32.58%6.50%-29.97%39.68%

Benchmark Metrics

HIVE Blockchain Technologies Ltd has an annualized alpha of 9.76%, beta of 2.01, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since January 16, 2018.

  • This stock participated in 198.47% of S&P 500 Index downside but only 123.52% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.13 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
9.76%
Beta
2.01
0.13
Upside Capture
123.52%
Downside Capture
198.47%

Return for Risk

Risk / Return Rank

HIVE ranks 53 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


HIVE Risk / Return Rank: 5353
Overall Rank
HIVE Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
HIVE Sortino Ratio Rank: 5959
Sortino Ratio Rank
HIVE Omega Ratio Rank: 5555
Omega Ratio Rank
HIVE Calmar Ratio Rank: 4949
Calmar Ratio Rank
HIVE Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and compare them to a chosen benchmark (S&P 500 Index).


HIVEBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.36

0.90

-0.54

Sortino ratio

Return per unit of downside risk

1.18

1.39

-0.20

Omega ratio

Gain probability vs. loss probability

1.14

1.21

-0.07

Calmar ratio

Return relative to maximum drawdown

0.36

1.40

-1.04

Martin ratio

Return relative to average drawdown

0.68

6.61

-5.92

Explore HIVE risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


HIVE Blockchain Technologies Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the HIVE Blockchain Technologies Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the HIVE Blockchain Technologies Ltd was 97.73%, occurring on Dec 17, 2019. Recovery took 267 trading sessions.

The current HIVE Blockchain Technologies Ltd drawdown is 92.92%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.73%Jan 16, 2018485Dec 17, 2019267Jan 8, 2021752
-95.12%Feb 22, 20211038Apr 8, 2025
-32.45%Jan 11, 202112Jan 27, 202112Feb 12, 202124

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of HIVE Blockchain Technologies Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how HIVE Blockchain Technologies Ltd is priced in the market compared to other companies in the Capital Markets industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HIVE relative to other companies in the Capital Markets industry. Currently, HIVE has a P/S ratio of 1.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HIVE in comparison with other companies in the Capital Markets industry. Currently, HIVE has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items